nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—Convulsion—Altretamine—ovarian cancer	0.0249	0.0288	CcSEcCtD
Methylergometrine—HTR2A—vein—ovarian cancer	0.023	0.185	CbGeAlD
Methylergometrine—HTR1E—myometrium—ovarian cancer	0.0199	0.16	CbGeAlD
Methylergometrine—Dizziness—Altretamine—ovarian cancer	0.0155	0.018	CcSEcCtD
Methylergometrine—Thrombophlebitis—Vinorelbine—ovarian cancer	0.0149	0.0173	CcSEcCtD
Methylergometrine—Vomiting—Altretamine—ovarian cancer	0.0149	0.0173	CcSEcCtD
Methylergometrine—Nausea—Altretamine—ovarian cancer	0.0139	0.0161	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Vinorelbine—ovarian cancer	0.0132	0.0153	CcSEcCtD
Methylergometrine—Atrioventricular block—Paclitaxel—ovarian cancer	0.0123	0.0143	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Paclitaxel—ovarian cancer	0.0119	0.0139	CcSEcCtD
Methylergometrine—Hallucination—Chlorambucil—ovarian cancer	0.0117	0.0135	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Paclitaxel—ovarian cancer	0.011	0.0127	CcSEcCtD
Methylergometrine—Angina pectoris—Vinorelbine—ovarian cancer	0.0109	0.0126	CcSEcCtD
Methylergometrine—HTR1E—female gonad—ovarian cancer	0.0106	0.085	CbGeAlD
Methylergometrine—Thrombophlebitis—Paclitaxel—ovarian cancer	0.01	0.0116	CcSEcCtD
Methylergometrine—Nasal congestion—Paclitaxel—ovarian cancer	0.00952	0.011	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.00885	0.0103	CcSEcCtD
Methylergometrine—Convulsion—Chlorambucil—ovarian cancer	0.00883	0.0103	CcSEcCtD
Methylergometrine—Muscle spasms—Topotecan—ovarian cancer	0.00873	0.0101	CcSEcCtD
Methylergometrine—Thrombophlebitis—Docetaxel—ovarian cancer	0.00849	0.00985	CcSEcCtD
Methylergometrine—HTR2B—myometrium—ovarian cancer	0.00848	0.0682	CbGeAlD
Methylergometrine—Cardiac disorder—Vinorelbine—ovarian cancer	0.00828	0.00961	CcSEcCtD
Methylergometrine—Chest pain—Topotecan—ovarian cancer	0.00773	0.00897	CcSEcCtD
Methylergometrine—Convulsion—Melphalan—ovarian cancer	0.0077	0.00894	CcSEcCtD
Methylergometrine—Chest pain—Melphalan—ovarian cancer	0.00757	0.00878	CcSEcCtD
Methylergometrine—Anaphylactic shock—Topotecan—ovarian cancer	0.00741	0.0086	CcSEcCtD
Methylergometrine—Sweating increased—Paclitaxel—ovarian cancer	0.0073	0.00847	CcSEcCtD
Methylergometrine—Nervous system disorder—Topotecan—ovarian cancer	0.00726	0.00843	CcSEcCtD
Methylergometrine—Anaphylactic shock—Melphalan—ovarian cancer	0.00725	0.00842	CcSEcCtD
Methylergometrine—Hyperhidrosis—Topotecan—ovarian cancer	0.00716	0.00831	CcSEcCtD
Methylergometrine—Tachycardia—Melphalan—ovarian cancer	0.00708	0.00821	CcSEcCtD
Methylergometrine—Atrioventricular block—Epirubicin—ovarian cancer	0.00704	0.00817	CcSEcCtD
Methylergometrine—Palpitations—Vinorelbine—ovarian cancer	0.00686	0.00796	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00683	0.00793	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.0068	0.0079	CcSEcCtD
Methylergometrine—Hypotension—Melphalan—ovarian cancer	0.00678	0.00787	CcSEcCtD
Methylergometrine—Hypertension—Vinorelbine—ovarian cancer	0.0067	0.00778	CcSEcCtD
Methylergometrine—Paraesthesia—Topotecan—ovarian cancer	0.00665	0.00772	CcSEcCtD
Methylergometrine—Chest pain—Vinorelbine—ovarian cancer	0.00661	0.00767	CcSEcCtD
Methylergometrine—Dyspnoea—Topotecan—ovarian cancer	0.0066	0.00766	CcSEcCtD
Methylergometrine—Ergonovine—ABCB1—ovarian cancer	0.0066	0.475	CrCbGaD
Methylergometrine—HTR2B—uterine cervix—ovarian cancer	0.0066	0.0531	CbGeAlD
Methylergometrine—Abdominal pain—Chlorambucil—ovarian cancer	0.00658	0.00763	CcSEcCtD
Methylergometrine—Atrioventricular block—Doxorubicin—ovarian cancer	0.00652	0.00756	CcSEcCtD
Methylergometrine—Paraesthesia—Melphalan—ovarian cancer	0.00651	0.00756	CcSEcCtD
Methylergometrine—Dyspnoea—Melphalan—ovarian cancer	0.00647	0.0075	CcSEcCtD
Methylergometrine—Haematuria—Paclitaxel—ovarian cancer	0.00637	0.00739	CcSEcCtD
Methylergometrine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00634	0.00735	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00632	0.00733	CcSEcCtD
Methylergometrine—HTR2B—decidua—ovarian cancer	0.00629	0.0506	CbGeAlD
Methylergometrine—Cramps of lower extremities—Epirubicin—ovarian cancer	0.00627	0.00728	CcSEcCtD
Methylergometrine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00621	0.00721	CcSEcCtD
Methylergometrine—Angina pectoris—Docetaxel—ovarian cancer	0.00619	0.00718	CcSEcCtD
Methylergometrine—Tachycardia—Vinorelbine—ovarian cancer	0.00618	0.00718	CcSEcCtD
Methylergometrine—Bradycardia—Paclitaxel—ovarian cancer	0.00611	0.00709	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00606	0.00703	CcSEcCtD
Methylergometrine—HTR2B—endometrium—ovarian cancer	0.00597	0.048	CbGeAlD
Methylergometrine—Hypotension—Vinorelbine—ovarian cancer	0.00592	0.00687	CcSEcCtD
Methylergometrine—Abdominal pain—Topotecan—ovarian cancer	0.00586	0.0068	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.00581	0.00674	CcSEcCtD
Methylergometrine—Thrombophlebitis—Epirubicin—ovarian cancer	0.00573	0.00665	CcSEcCtD
Methylergometrine—Diarrhoea—Chlorambucil—ovarian cancer	0.00569	0.00661	CcSEcCtD
Methylergometrine—Paraesthesia—Vinorelbine—ovarian cancer	0.00569	0.0066	CcSEcCtD
Methylergometrine—Dyspnoea—Vinorelbine—ovarian cancer	0.00565	0.00656	CcSEcCtD
Methylergometrine—Tinnitus—Paclitaxel—ovarian cancer	0.00559	0.00649	CcSEcCtD
Methylergometrine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00557	0.00646	CcSEcCtD
Methylergometrine—HTR2B—uterus—ovarian cancer	0.0055	0.0442	CbGeAlD
Methylergometrine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.0053	0.00615	CcSEcCtD
Methylergometrine—Vomiting—Chlorambucil—ovarian cancer	0.00529	0.00614	CcSEcCtD
Methylergometrine—HTR2C—female reproductive system—ovarian cancer	0.00526	0.0423	CbGeAlD
Methylergometrine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00518	0.00601	CcSEcCtD
Methylergometrine—Diarrhoea—Topotecan—ovarian cancer	0.00507	0.00588	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Epirubicin—ovarian cancer	0.00506	0.00587	CcSEcCtD
Methylergometrine—Muscle spasms—Paclitaxel—ovarian cancer	0.00502	0.00583	CcSEcCtD
Methylergometrine—Abdominal pain—Vinorelbine—ovarian cancer	0.00501	0.00581	CcSEcCtD
Methylergometrine—Diarrhoea—Melphalan—ovarian cancer	0.00496	0.00576	CcSEcCtD
Methylergometrine—HTR2B—female reproductive system—ovarian cancer	0.00494	0.0398	CbGeAlD
Methylergometrine—Nausea—Chlorambucil—ovarian cancer	0.00494	0.00574	CcSEcCtD
Methylergometrine—Dizziness—Topotecan—ovarian cancer	0.0049	0.00568	CcSEcCtD
Methylergometrine—Cardiac disorder—Docetaxel—ovarian cancer	0.00472	0.00548	CcSEcCtD
Methylergometrine—Vomiting—Topotecan—ovarian cancer	0.00471	0.00547	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00468	0.00543	CcSEcCtD
Methylergometrine—Rash—Topotecan—ovarian cancer	0.00467	0.00542	CcSEcCtD
Methylergometrine—Dermatitis—Topotecan—ovarian cancer	0.00467	0.00542	CcSEcCtD
Methylergometrine—Headache—Topotecan—ovarian cancer	0.00464	0.00539	CcSEcCtD
Methylergometrine—Palpitations—Paclitaxel—ovarian cancer	0.00462	0.00536	CcSEcCtD
Methylergometrine—Vomiting—Melphalan—ovarian cancer	0.00461	0.00535	CcSEcCtD
Methylergometrine—Rash—Melphalan—ovarian cancer	0.00457	0.00531	CcSEcCtD
Methylergometrine—Dermatitis—Melphalan—ovarian cancer	0.00457	0.0053	CcSEcCtD
Methylergometrine—Convulsion—Paclitaxel—ovarian cancer	0.00453	0.00525	CcSEcCtD
Methylergometrine—Hypertension—Paclitaxel—ovarian cancer	0.00451	0.00523	CcSEcCtD
Methylergometrine—HTR2B—vagina—ovarian cancer	0.00447	0.036	CbGeAlD
Methylergometrine—Chest pain—Paclitaxel—ovarian cancer	0.00445	0.00516	CcSEcCtD
Methylergometrine—Nausea—Topotecan—ovarian cancer	0.0044	0.00511	CcSEcCtD
Methylergometrine—HTR2A—embryo—ovarian cancer	0.00436	0.035	CbGeAlD
Methylergometrine—Diarrhoea—Vinorelbine—ovarian cancer	0.00434	0.00503	CcSEcCtD
Methylergometrine—Nausea—Melphalan—ovarian cancer	0.00431	0.005	CcSEcCtD
Methylergometrine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00426	0.00495	CcSEcCtD
Methylergometrine—Muscle spasms—Docetaxel—ovarian cancer	0.00426	0.00494	CcSEcCtD
Methylergometrine—Dizziness—Vinorelbine—ovarian cancer	0.00419	0.00486	CcSEcCtD
Methylergometrine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00418	0.00485	CcSEcCtD
Methylergometrine—Angina pectoris—Epirubicin—ovarian cancer	0.00417	0.00484	CcSEcCtD
Methylergometrine—Tachycardia—Paclitaxel—ovarian cancer	0.00416	0.00483	CcSEcCtD
Methylergometrine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00412	0.00478	CcSEcCtD
Methylergometrine—Vomiting—Vinorelbine—ovarian cancer	0.00403	0.00468	CcSEcCtD
Methylergometrine—Rash—Vinorelbine—ovarian cancer	0.004	0.00464	CcSEcCtD
Methylergometrine—Dermatitis—Vinorelbine—ovarian cancer	0.00399	0.00463	CcSEcCtD
Methylergometrine—Hypotension—Paclitaxel—ovarian cancer	0.00398	0.00462	CcSEcCtD
Methylergometrine—Headache—Vinorelbine—ovarian cancer	0.00397	0.00461	CcSEcCtD
Methylergometrine—Palpitations—Docetaxel—ovarian cancer	0.00391	0.00454	CcSEcCtD
Methylergometrine—Angina pectoris—Doxorubicin—ovarian cancer	0.00386	0.00448	CcSEcCtD
Methylergometrine—Convulsion—Docetaxel—ovarian cancer	0.00384	0.00445	CcSEcCtD
Methylergometrine—Paraesthesia—Paclitaxel—ovarian cancer	0.00383	0.00444	CcSEcCtD
Methylergometrine—Hypertension—Docetaxel—ovarian cancer	0.00382	0.00444	CcSEcCtD
Methylergometrine—Dyspnoea—Paclitaxel—ovarian cancer	0.0038	0.00441	CcSEcCtD
Methylergometrine—Chest pain—Docetaxel—ovarian cancer	0.00377	0.00437	CcSEcCtD
Methylergometrine—Nausea—Vinorelbine—ovarian cancer	0.00376	0.00437	CcSEcCtD
Methylergometrine—Ergotamine—ABCB1—ovarian cancer	0.00372	0.267	CrCbGaD
Methylergometrine—Haematuria—Epirubicin—ovarian cancer	0.00364	0.00423	CcSEcCtD
Methylergometrine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00361	0.00419	CcSEcCtD
Methylergometrine—Bromocriptine—ABCB1—ovarian cancer	0.00359	0.258	CrCbGaD
Methylergometrine—HTR2A—epithelium—ovarian cancer	0.00355	0.0286	CbGeAlD
Methylergometrine—Nervous system disorder—Docetaxel—ovarian cancer	0.00354	0.00411	CcSEcCtD
Methylergometrine—Tachycardia—Docetaxel—ovarian cancer	0.00353	0.00409	CcSEcCtD
Methylergometrine—Bradycardia—Epirubicin—ovarian cancer	0.00349	0.00405	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00349	0.00404	CcSEcCtD
Methylergometrine—Hypotension—Docetaxel—ovarian cancer	0.00338	0.00392	CcSEcCtD
Methylergometrine—Haematuria—Doxorubicin—ovarian cancer	0.00337	0.00391	CcSEcCtD
Methylergometrine—Abdominal pain—Paclitaxel—ovarian cancer	0.00337	0.00391	CcSEcCtD
Methylergometrine—Paraesthesia—Docetaxel—ovarian cancer	0.00324	0.00376	CcSEcCtD
Methylergometrine—Bradycardia—Doxorubicin—ovarian cancer	0.00323	0.00375	CcSEcCtD
Methylergometrine—Dyspnoea—Docetaxel—ovarian cancer	0.00322	0.00374	CcSEcCtD
Methylergometrine—Tinnitus—Epirubicin—ovarian cancer	0.0032	0.00371	CcSEcCtD
Methylergometrine—Cardiac disorder—Epirubicin—ovarian cancer	0.00318	0.00369	CcSEcCtD
Methylergometrine—Tinnitus—Doxorubicin—ovarian cancer	0.00296	0.00343	CcSEcCtD
Methylergometrine—HTR2A—gonad—ovarian cancer	0.00296	0.0238	CbGeAlD
Methylergometrine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00295	0.00343	CcSEcCtD
Methylergometrine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00295	0.00342	CcSEcCtD
Methylergometrine—Diarrhoea—Paclitaxel—ovarian cancer	0.00292	0.00338	CcSEcCtD
Methylergometrine—HTR2B—lymph node—ovarian cancer	0.00289	0.0233	CbGeAlD
Methylergometrine—Muscle spasms—Epirubicin—ovarian cancer	0.00287	0.00333	CcSEcCtD
Methylergometrine—Abdominal pain—Docetaxel—ovarian cancer	0.00286	0.00331	CcSEcCtD
Methylergometrine—Dizziness—Paclitaxel—ovarian cancer	0.00282	0.00327	CcSEcCtD
Methylergometrine—Vomiting—Paclitaxel—ovarian cancer	0.00271	0.00314	CcSEcCtD
Methylergometrine—Rash—Paclitaxel—ovarian cancer	0.00269	0.00312	CcSEcCtD
Methylergometrine—Dermatitis—Paclitaxel—ovarian cancer	0.00269	0.00312	CcSEcCtD
Methylergometrine—Headache—Paclitaxel—ovarian cancer	0.00267	0.0031	CcSEcCtD
Methylergometrine—Muscle spasms—Doxorubicin—ovarian cancer	0.00266	0.00308	CcSEcCtD
Methylergometrine—HTR2A—female reproductive system—ovarian cancer	0.00264	0.0212	CbGeAlD
Methylergometrine—Palpitations—Epirubicin—ovarian cancer	0.00264	0.00306	CcSEcCtD
Methylergometrine—Convulsion—Epirubicin—ovarian cancer	0.00259	0.003	CcSEcCtD
Methylergometrine—Hypertension—Epirubicin—ovarian cancer	0.00258	0.00299	CcSEcCtD
Methylergometrine—Chest pain—Epirubicin—ovarian cancer	0.00254	0.00295	CcSEcCtD
Methylergometrine—Nausea—Paclitaxel—ovarian cancer	0.00253	0.00294	CcSEcCtD
Methylergometrine—Diarrhoea—Docetaxel—ovarian cancer	0.00247	0.00287	CcSEcCtD
Methylergometrine—CYP3A4—female reproductive system—ovarian cancer	0.00244	0.0197	CbGeAlD
Methylergometrine—Palpitations—Doxorubicin—ovarian cancer	0.00244	0.00283	CcSEcCtD
Methylergometrine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00244	0.00283	CcSEcCtD
Methylergometrine—Convulsion—Doxorubicin—ovarian cancer	0.00239	0.00278	CcSEcCtD
Methylergometrine—Nervous system disorder—Epirubicin—ovarian cancer	0.00239	0.00277	CcSEcCtD
Methylergometrine—Dizziness—Docetaxel—ovarian cancer	0.00239	0.00277	CcSEcCtD
Methylergometrine—HTR2A—vagina—ovarian cancer	0.00239	0.0192	CbGeAlD
Methylergometrine—Hypertension—Doxorubicin—ovarian cancer	0.00239	0.00277	CcSEcCtD
Methylergometrine—Tachycardia—Epirubicin—ovarian cancer	0.00238	0.00276	CcSEcCtD
Methylergometrine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00236	0.00273	CcSEcCtD
Methylergometrine—Chest pain—Doxorubicin—ovarian cancer	0.00235	0.00273	CcSEcCtD
Methylergometrine—Vomiting—Docetaxel—ovarian cancer	0.0023	0.00267	CcSEcCtD
Methylergometrine—Rash—Docetaxel—ovarian cancer	0.00228	0.00264	CcSEcCtD
Methylergometrine—Hypotension—Epirubicin—ovarian cancer	0.00228	0.00264	CcSEcCtD
Methylergometrine—Dermatitis—Docetaxel—ovarian cancer	0.00228	0.00264	CcSEcCtD
Methylergometrine—Headache—Docetaxel—ovarian cancer	0.00226	0.00263	CcSEcCtD
Methylergometrine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00225	0.00262	CcSEcCtD
Methylergometrine—Nervous system disorder—Doxorubicin—ovarian cancer	0.00221	0.00257	CcSEcCtD
Methylergometrine—Tachycardia—Doxorubicin—ovarian cancer	0.0022	0.00255	CcSEcCtD
Methylergometrine—Paraesthesia—Epirubicin—ovarian cancer	0.00219	0.00254	CcSEcCtD
Methylergometrine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00218	0.00253	CcSEcCtD
Methylergometrine—Dyspnoea—Epirubicin—ovarian cancer	0.00217	0.00252	CcSEcCtD
Methylergometrine—Nausea—Docetaxel—ovarian cancer	0.00215	0.00249	CcSEcCtD
Methylergometrine—HTR2A—testis—ovarian cancer	0.00213	0.0171	CbGeAlD
Methylergometrine—Hypotension—Doxorubicin—ovarian cancer	0.00211	0.00244	CcSEcCtD
Methylergometrine—Paraesthesia—Doxorubicin—ovarian cancer	0.00202	0.00235	CcSEcCtD
Methylergometrine—Dyspnoea—Doxorubicin—ovarian cancer	0.00201	0.00233	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00199	0.00231	CcSEcCtD
Methylergometrine—Abdominal pain—Epirubicin—ovarian cancer	0.00193	0.00224	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00184	0.00214	CcSEcCtD
Methylergometrine—Abdominal pain—Doxorubicin—ovarian cancer	0.00178	0.00207	CcSEcCtD
Methylergometrine—Diarrhoea—Epirubicin—ovarian cancer	0.00167	0.00193	CcSEcCtD
Methylergometrine—Dizziness—Epirubicin—ovarian cancer	0.00161	0.00187	CcSEcCtD
Methylergometrine—Vomiting—Epirubicin—ovarian cancer	0.00155	0.0018	CcSEcCtD
Methylergometrine—Diarrhoea—Doxorubicin—ovarian cancer	0.00154	0.00179	CcSEcCtD
Methylergometrine—Rash—Epirubicin—ovarian cancer	0.00154	0.00178	CcSEcCtD
Methylergometrine—Dermatitis—Epirubicin—ovarian cancer	0.00154	0.00178	CcSEcCtD
Methylergometrine—Headache—Epirubicin—ovarian cancer	0.00153	0.00177	CcSEcCtD
Methylergometrine—Dizziness—Doxorubicin—ovarian cancer	0.00149	0.00173	CcSEcCtD
Methylergometrine—Nausea—Epirubicin—ovarian cancer	0.00145	0.00168	CcSEcCtD
Methylergometrine—Vomiting—Doxorubicin—ovarian cancer	0.00143	0.00166	CcSEcCtD
Methylergometrine—Rash—Doxorubicin—ovarian cancer	0.00142	0.00165	CcSEcCtD
Methylergometrine—Dermatitis—Doxorubicin—ovarian cancer	0.00142	0.00165	CcSEcCtD
Methylergometrine—Headache—Doxorubicin—ovarian cancer	0.00141	0.00164	CcSEcCtD
Methylergometrine—Nausea—Doxorubicin—ovarian cancer	0.00134	0.00155	CcSEcCtD
